Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-066825
Filing Date
2021-12-21
Accepted
2021-12-21 21:31:14
Documents
1
Period of Report
2021-12-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3941
  Complete submission text file 0001213900-21-066825.txt   5348
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 138 CANTERBURY LN BLUE BELL PA 19422
Business Address
TRAVERSA SERGIO (Reporting) CIK: 0001565832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 211510853